This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mandapaka, S. Articles by Hundley, W. G. Search for Related Content PubMed PubMed Citation Articles by Mandapaka, S. Articles by Hundley, W. G. Related Collections Other heart failure CT and MRI Chronic ischemic heart disease

(Circulation. 2006;113:2676-2678.)
© 2006 American Heart Association, Inc.

Editorial

Does Late Gadolinium Enhancement Predict Cardiac Events in Patients With Ischemic Cardiomyopathy?

Sangeeta Mandapaka, MD; Ralph D’Agostino, Jr, PhD; W. Gregory Hundley, MD

From the Departments of Internal Medicine (Sections on Cardiology and Hematology/Oncology) (S.M., R.D., W.G.H.), Public Health Sciences (R.D.), and Radiology (W.G.H.), Wake Forest University School of Medicine, Winston-Salem, NC.

Correspondence to W. Gregory Hundley, MD, Section on Cardiology, Wake Forest University School of Medicine, Bowman Gray Campus, Medical Center Boulevard, Winston-Salem, NC 27157–1045. E-mail ghundley@wfubmc.edu

Key Words: Editorials • cardiomyopathy • magnetic resonance imaging • myocardial infarction

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Despite improved clinical care and heightened public awareness, myocardial infarction (MI) and sudden cardiac death remain the leading causes of death in the United States.¹ For this reason, clinical,² laboratory,³ and electrocardiographic⁴ markers to identify those at risk for future cardiac events have been developed. In addition, both invasive (contrast angiography)^5,6 and noninvasive (transthoracic echocardiography,⁷ radionuclide scintigraphy,⁸ magnetic resonance,⁹ and computer tomography¹⁰) imaging markers have been identified that further supplement the clinical markers to more accurately define cardiac risk. For the most part, these imaging markers rely on rest or stress measures of left ventricular (LV) ejection fraction,¹¹ regional wall motion,¹² myocardial perfusion,¹³ or the extent of coronary atherosclerosis.¹⁴ With the exception of coronary artery calcification scoring generated from computer tomography image datasets,¹⁵ there have been few new imaging markers (introduced during the past 15 years) that add incremental benefit to our ability to identify cardiac risk.

Article p 2733

Late gadolinium enhancement (LGE) cardiac imaging was introduced by Saeed et al¹⁶ in 1989, to identify infarcted myocardial tissue during cardiovascular magnetic resonance (CMR). This technique incorporates the administration of relatively inert extracellular gadolinium contrast during gradient-echo inversion recovery imaging.¹⁷ On image acquisition, areas of noninfarcted tissue appear dark, and infarcted or fibrotic tissue appears bright because of reduced clearance and increased volume of distribution of the gadolinium.¹⁶ This fundamental aspect of delayed enhancement imaging has led to the recent expression, "bright is dead."

Combining the ability to characterize myocardial tissue with the heightened spatial resolution of CMR (voxel . . . [Full Text of this Article]